These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


495 related items for PubMed ID: 29557260

  • 1. 'Palliative sedation'? A retrospective cohort study on the use and labelling of continuously administered sedatives on a palliative care unit.
    Schildmann E, Pörnbacher S, Kalies H, Bausewein C.
    Palliat Med; 2018 Jul; 32(7):1189-1197. PubMed ID: 29557260
    [Abstract] [Full Text] [Related]

  • 2. Sedatives and sedation at the end of life: a nursing home retrospective cohort study.
    Schildmann E, Bolzani A, Meesters S, Grüne B, Marheineke A, Remi C, Bausewein C.
    BMJ Support Palliat Care; 2022 Dec; 12(e6):e744-e747. PubMed ID: 31780449
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Discussions about palliative sedation in hospice: Frequency, timing and factors associated with patient involvement.
    Ingravallo F, de Nooijer K, Pucci V, Casini C, Miccinesi G, Rietjens JAC, Morino P.
    Eur J Cancer Care (Engl); 2019 May; 28(3):e13019. PubMed ID: 30773765
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Dexmedetomidine Versus Midazolam for End-of-Life Sedation and Agitation: Protocol for a Randomized Controlled Trial (The DREAMS Trial).
    Thomas B, Barclay G, Lo WA, Mullan J, Mansfield K.
    JMIR Res Protoc; 2024 Sep 04; 13():e55129. PubMed ID: 39230940
    [Abstract] [Full Text] [Related]

  • 7. Palliative sedation: A safety net for the relief of refractory and intolerable symptoms at the end of life.
    Patel C, Kleinig P, Bakker M, Tait P.
    Aust J Gen Pract; 2019 Dec 04; 48(12):838-845. PubMed ID: 31774984
    [Abstract] [Full Text] [Related]

  • 8. Prehospital Agitation and Sedation Trial (PhAST): A Randomized Control Trial of Intramuscular Haloperidol versus Intramuscular Midazolam for the Sedation of the Agitated or Violent Patient in the Prehospital Environment.
    Isenberg DL, Jacobs D.
    Prehosp Disaster Med; 2015 Oct 04; 30(5):491-5. PubMed ID: 26323511
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Propofol for palliative sedation.
    Sulistio M, Wojnar R, Michael NG.
    BMJ Support Palliat Care; 2020 Mar 04; 10(1):4-6. PubMed ID: 31488420
    [Abstract] [Full Text] [Related]

  • 12. A protocol for the acute control of agitation in palliative care: a preliminary report.
    Gonçalves F, Almeida A, Teixeira S, Pereira S, Edra N.
    Am J Hosp Palliat Care; 2012 Nov 04; 29(7):522-4. PubMed ID: 22363035
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Sedative use in the last week of life and the implications for end-of-life decision making.
    Sykes N, Thorns A.
    Arch Intern Med; 2003 Feb 10; 163(3):341-4. PubMed ID: 12578515
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Do we need a more precise definition of what sedation is?].
    Sanz Rubiales Á, Barón Duarte F, del Valle Rivero ML.
    Cuad Bioet; 2015 Feb 10; 26(86):111-6. PubMed ID: 26030016
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Sedation in the terminal phase of life].
    Verhagen EH, Eliel MR, de Graeff A, Teunissen SC.
    Ned Tijdschr Geneeskd; 1999 Dec 25; 143(52):2601-3. PubMed ID: 10633803
    [Abstract] [Full Text] [Related]

  • 19. [Palliative sedation at a university palliative care unit--a descriptive analysis].
    Hopprich A, Günther LD, Laufenberg-Feldmann R, Reinholz U, Weber M.
    Dtsch Med Wochenschr; 2016 Apr 25; 141(8):e60-6. PubMed ID: 27078251
    [Abstract] [Full Text] [Related]

  • 20. Palliative care specialists in hospice and hospital/community teams predominantly use low doses of sedative medication at the end of life for patient comfort rather than sedation: Findings from focus groups and patient records for I-CAN-CARE.
    Vivat B, Bemand-Qureshi L, Harrington J, Davis S, Stone P.
    Palliat Med; 2019 Jun 25; 33(6):578-588. PubMed ID: 30747052
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 25.